Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

by Kumar, S K, LaPlant, B, Roy, V, Reeder, C B, Lacy, M Q, Gertz, M A, Laumann, K, Thompson, M A, Witzig, T E, Buadi, F K, Rivera, C E, Mikhael, J R, Bergsagel, P L, Kapoor, P, Hwa, L, Fonseca, R, Stewart, A K, Chanan-Khan, A, Rajkumar, S V, Dispenzieri, A
Published 2015

The Herschel-ATLAS data release 1: II. Multi-wavelength counterparts to submillimetre sources

by Bourne, N., Dunne, L., Maddox, S.J., Dye, S., Furlanetto, C., Hoyos, Carlos, Smith, D.J.B., Eales, S., Smith, M.W.L., Valiante, E., Alpaslan, M., Andrae, E., Baldry, I.K., Cluver, M.E., Cooray, A., Driver, S.P., Dunlop, J.S., Grootes, M.W., Ivison, R.J., Jarrett, Tom, Liske, J., Madore, B.F., Popescu, C.C., Robotham, A.G., Rowlands, K., Seibert, M., Thompson, M.A., Tuffs, Richard J., Viaene, S., Wright, A.H.
Published 2016